EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Germline TP53 pathogenic variants and breast cancer: A narrative review

Eva Blondeaux, Luca Arecco, Kevin Punie, Rossella Graffeo, Angela Toss, Carmine De Angelis, Lucia Trevisan, Giulia Buzzatti, Sabine C Linn, Peter Dubsky, Mara Cruellas, Ann H Partridge und 3 weitere

Cancer Treatment Reviews · 2023-03 · 114 · 102522

DOI: 10.1016/j.ctrv.2023.102522 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2023-03. Verfasst von Eva Blondeaux und 14 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: evablondeaux@gmail.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Li-Fraumeni Syndrome, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLi-Fraumeni SyndromeTumor Suppressor Protein p53ChildFemaleHumansGenetic Predisposition to DiseaseMastectomy

Stichwörter der Autor:innen

Breast cancerPrognosisTP53Treatment

Substanzen

TP53 protein, humanTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: evablondeaux@gmail.com.
  • Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Ma…
  • Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
  • Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.

Förderung

  • Gilead Sciences

Zitieren

APA

Blondeaux, E., Arecco, L., Punie, K., Graffeo, R., Toss, A., De Angelis, C., Trevisan, L., Buzzatti, G., Linn, S. C., Dubsky, P., Cruellas, M., Partridge, A. H., Balmaña, J., Paluch-Shimon, S., & Lambertini, M. (2023). Germline TP53 pathogenic variants and breast cancer: A narrative review. Cancer Treatment Reviews, 114, 102522. https://doi.org/10.1016/j.ctrv.2023.102522

Vancouver

Blondeaux E, Arecco L, Punie K, Graffeo R, Toss A, De Angelis C, et al. Germline TP53 pathogenic variants and breast cancer: A narrative review. Cancer Treatment Reviews. 2023;114:102522. doi:10.1016/j.ctrv.2023.102522

BibTeX
@article{Blondeaux2023,
  author = {Blondeaux, Eva and Arecco, Luca and Punie, Kevin and Graffeo, Rossella and Toss, Angela and De Angelis, Carmine and Trevisan, Lucia and Buzzatti, Giulia and Linn, Sabine C and Dubsky, Peter and Cruellas, Mara and Partridge, Ann H and Balmaña, Judith and Paluch-Shimon, Shani and Lambertini, Matteo},
  title = {Germline TP53 pathogenic variants and breast cancer: A narrative review},
  journal = {Cancer Treatment Reviews},
  year = {2023},
  volume = {114},
  pages = {102522},
  doi = {10.1016/j.ctrv.2023.102522}
}
Kostenlos starten →